Risk Estimation in Type 2 Myocardial Infarction and Myocardial Injury: The TARRACO Risk Score

Cardiac troponin (cTn) is the recommended and preferred biomarker for diagnosing acute myocardial infarction.1,2 The use of high-sensitivity cTn assays and broad testing across various clinical scenarios has led to a progressive increase in the number of patients displaying increased cTn concentrations >99th percentile in the settings of acute and chronic pathologies other than type 1 myocardial infarction. Several studies suggest that most increased levels of cTn in contemporary practice are due to either type 2 myocardial infarction or myocardial injury.

About admin

Now Dr. Jack Straw is in charge of the website, and organizes it so that medical care is available to everyone. In addition, he is an active member of the medical community, regularly attending international conferences and sharing his experience and knowledge. Dr. Straw is not only a medical professional and website manager, but also a loving husband and father of his beautiful children.
View all posts by admin →

Leave a Reply

Your email address will not be published. Required fields are marked *